Month |
Publication |
Title |
December |
Financial Express |
Orchid JV's Diabetic Drug Gets Nod For Human Trial |
December |
Business Standard |
Orchid arm gets nod for diabetes molecule trail |
December |
Business Line |
Orchid diabetic drug to start human trials in Europe |
December |
The Economic Times |
Orchid's anti-diabetic drug ready for clinical trials |
December |
The Hindu |
Nod for Orchid JV |
December |
Financial Express |
Orchid Gets FDA Nod For Cefazolin |
November |
Business Line |
Orchid Chem looks West to boost sales |
October |
Business Line |
Orchid's bulk drug unit gets EU nod |
September |
The Economic Times |
Orchid's JV manufacturing facility to roll on in China |
September |
Business Standard |
Orchid's China venture kicks off |
September |
Business Line |
Orchid eyes Rs 1,000-cr turnover by 2005
Chinese venture operations begin |
September |
The Hindu |
Orchid's JV facility in China Commissioned |
September |
Business Standard |
Orchid steps ahead on drug discovery path |
September |
Business Line |
Orchid bullish on `path-breaking' drug discovery |
September |
Financial Express |
Orchid Chemicals To License Out Anti-diabetic Molecule To MNC |
July |
Business Line |
Formulation unit to play key role in Orchid Chem growth |
July |
Business Line |
Co-marketing pacts boost Orchid's formulations sales |
July |
Financial Express |
Orchid US Arm Makes Strides In Drug Discovery |
July |
Business Standard |
Orchid says JV with Bexel is on course |
June |
The Hindu |
Partners in social progress |
June |
Financial Express |
Orchid Plans To File 12 ANDAs In US |
June |
The Economic Times |
Apotex, Orchid join hands to tap N American market |
June |
The New Indian Express |
Orchid in exclusive pact with Apotex |
June |
The Hindu |
Orchid's pact with U.S. firm |
June |
Business Line |
Sale of injectible medicines - Orchid signs marketing pact with US co Apotex |
June |
Financial Express |
Orchid Chem Ties Up With Apotex |
June |
Business Standard |
Orchid inks supply pact with Apotex |
June |
Pharmabiz |
Orchid signs exclusive pact with Apotex to market injectable antibiotics in the US |
May |
The Economic Times |
Orchid Chem focuses on exports to drive sales |
May |
Financial Express |
Orchid Sees 40% Sales Rise After South American Foray |
May |
The New Indian Express |
Orchid Chemicals eyes Chinese market for high value formulations |
May |
Business Standard |
Orchid Chemicals |
May |
Business Line |
Orchid Chem to launch two products from Chinese jt venture |
May |
Business Standard |
|
May |
Business Line |
Orchid seeks USFDA nod for Cephazolin |
April |
The Economic Times |
Orchid '03 net zooms 210% to Rs 20 cr |
April |
The Economic Times |
|
April |
Business Line |
Orchid Chem keen on DNA library |
April |
Business Standard |
|
February |
Pharma Biz |
Orchid's flagship product Cephalexin approved by USFDA |
February |
The Economic Times |
Orchid drug approved by USFDA |
February |
The Times of India |
Orchid drug approved by USFDA |
February |
Financial Express |
Orchid Chem Gets USFDA Approval For Cephalexin |
February |
Business Line |
Orchid gets USFDA nod for Cephalexin |
February |
Business Line |
Orchid Chem to develop new molecules in US |
January |
The Economic Times |
Mano buy plants Orchid in Formulations turf |
January |
Financial Express |
Orchid Chemicals Net Rises To Rs 3.72 Crore |